Triple

T5166980
Position Surface form Disambiguated ID Type / Status
Subject Center for Clinical Standards and Quality E116583 entity
Predicate overseesProgram P86 FINISHED
Object Value-Based Purchasing programs
Value-Based Purchasing programs are healthcare reimbursement initiatives that tie provider payments to the quality and efficiency of care delivered, incentivizing better outcomes and patient experiences.
E87669 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Value-Based Purchasing programs | Statement: [Center for Clinical Standards and Quality, overseesProgram, Value-Based Purchasing programs]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Value-Based Purchasing programs
Context triple: [Center for Clinical Standards and Quality, overseesProgram, Value-Based Purchasing programs]
  • A. 340B Drug Pricing Program
    The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
  • B. Accountable Care Organizations
    Accountable Care Organizations are collaborative networks of doctors, hospitals, and other healthcare providers that jointly take responsibility for the quality and cost of care for a defined patient population.
  • C. Center for Medicare and Medicaid Innovation
    The Center for Medicare and Medicaid Innovation is a federal agency within CMS that tests and implements new payment and service delivery models to improve quality and reduce costs in Medicare, Medicaid, and CHIP.
  • D. Prime Therapeutics
    Prime Therapeutics is a U.S.-based pharmacy benefit management company that administers prescription drug benefits for health plans, employers, and government programs.
  • E. Office of Program Integrity
    The Office of Program Integrity is a unit within the Oregon Department of Human Services responsible for preventing, detecting, and addressing fraud, waste, and abuse in the agency’s programs.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Value-Based Purchasing programs
Triple: [Center for Clinical Standards and Quality, overseesProgram, Value-Based Purchasing programs]
Generated description
Value-Based Purchasing programs are healthcare reimbursement initiatives that tie provider payments to the quality and efficiency of care delivered, incentivizing better outcomes and patient experiences.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Value-Based Purchasing programs
Target entity description: Value-Based Purchasing programs are healthcare reimbursement initiatives that tie provider payments to the quality and efficiency of care delivered, incentivizing better outcomes and patient experiences.
  • A. 340B Drug Pricing Program
    The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
  • B. Accountable Care Organizations
    Accountable Care Organizations are collaborative networks of doctors, hospitals, and other healthcare providers that jointly take responsibility for the quality and cost of care for a defined patient population.
  • C. Center for Medicare and Medicaid Innovation chosen
    The Center for Medicare and Medicaid Innovation is a federal agency within CMS that tests and implements new payment and service delivery models to improve quality and reduce costs in Medicare, Medicaid, and CHIP.
  • D. Prime Therapeutics
    Prime Therapeutics is a U.S.-based pharmacy benefit management company that administers prescription drug benefits for health plans, employers, and government programs.
  • E. Office of Program Integrity
    The Office of Program Integrity is a unit within the Oregon Department of Human Services responsible for preventing, detecting, and addressing fraud, waste, and abuse in the agency’s programs.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd445ff97c81909a2615cc56235470 completed March 20, 2026, 12:58 p.m.
NER Named-entity recognition batch_69bd792c5ea88190b6aa0e519c744155 completed March 20, 2026, 4:43 p.m.
NED1 Entity disambiguation (via context triple) batch_69bed93b85188190927d448e09a46425 completed March 21, 2026, 5:45 p.m.
NEDg Description generation batch_69bedbd301088190908d050425c6cda7 completed March 21, 2026, 5:56 p.m.
NED2 Entity disambiguation (via description) batch_69bedc65fcdc8190bc99c0d049e4dd94 completed March 21, 2026, 5:59 p.m.
Created at: March 20, 2026, 1:45 p.m.